Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.
In 2007, five Emerging Infections Program (EIP) sites were funded to determine the feasibility of establishing a population-based surveillance system for monitoring the effect of human papillomavirus (HPV) vaccine on pre-invasive cervical lesions. The project involved active population-based surveillance of cervical intraepithelial neoplasia grades 2 and 3 and adenocarcinoma in situ as well as associated HPV types in women >18 years of age residing in defined catchment areas; collecting relevant clinical information and detailed HPV vaccination histories for women 18-39 years of age; and estimating the annual rate of cervical cancer screening among the catchment area population. The first few years of the project provided key information, including data on HPV type distribution, before expected effect of vaccine introduction. The project's success exemplifies the flexibility of EIP's network to expand core activities to include emerging surveillance needs beyond acute infectious diseases. Project results contribute key information regarding the impact of HPV vaccination in the United States.
Susan
S
Hariri
Lauri E
LE
Markowitz
Nancy M
NM
Bennett
Linda M
LM
Niccolai
Sean
S
Schafer
Karen
K
Bloch
Ina U
IU
Park
Mary W
MW
Scahill
Pamela
P
Julian
Nasreen
N
Abdullah
Diane
D
Levine
Erin
E
Whitney
Elizabeth R
ER
Unger
Martin
M
Steinau
Heidi M
HM
Bauer
James
J
Meek
James
J
Hadler
Lynn
L
Sosa
Suzanne E
SE
Powell
Michelle L
ML
Johnson
D000293:Adolescent; D000328:Adult; D021821:Communicable Diseases, Emerging / Q000453:epidemiology* / Q000517:prevention & control; D005260:Female; D006801:Humans; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage; D062486:Public Health Surveillance; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D014611:Vaccination; D016387:Women's Health; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control
D053918:Papillomavirus Vaccines
CIN; CIN2; CIN3; Emerging Infections Program; HPV; HPV vaccine; United States; adenocarcinoma in situ; cancer; cervical intraepithelial neoplasia; cervical precancer; human papillomavirus; vaccination; vaccine effect; viruses